Abstract:Background: The use of routinely collected health data for secondary research purposes is increasingly recognised as a methodology that advances medical research, improves patient outcomes, and guides policy. This secondary data, as found in electronic medical records (EMRs), can be optimised through conversion into a uniform data structure to enable analysis alongside other comparable health metric datasets. This can be achieved with the Observational Medical Outcomes Partnership Common Data Model (OMOP-CDM), which employs a standardised vocabulary to facilitate systematic analysis across various observational databases. The concept behind the OMOP-CDM is the conversion of data into a common format through the harmonisation of terminologies, vocabularies, and coding schemes within a unique repository. The OMOP model enhances research capacity through the development of shared analytic and prediction techniques; pharmacovigilance for the active surveillance of drug safety; and 'validation' analyses across multiple institutions across Australia, the United States, Europe, and the Asia Pacific. In this research, we aim to investigate the use of the open-source OMOP-CDM in the PATRON primary care data repository. Methods: We used standard structured query language (SQL) to construct, extract, transform, and load scripts to convert the data to the OMOP-CDM. The process of mapping distinct free-text terms extracted from various EMRs presented a substantial challenge, as many terms could not be automatically matched to standard vocabularies through direct text comparison. This resulted in a number of terms that required manual assignment. To address this issue, we implemented a strategy where our clinical mappers were instructed to focus only on terms that appeared with sufficient frequency. We established a specific threshold value for each domain, ensuring that more than 95% of all records were linked to an approved vocabulary like SNOMED once appropriate mapping was completed. To assess the data quality of the resultant OMOP dataset we utilised the OHDSI Data Quality Dashboard (DQD) to evaluate the plausibility, conformity, and comprehensiveness of the data in the PATRON repository according to the Kahn framework. Results: Across three primary care EMR systems we converted data on 2.03 million active patients to version 5.4 of the OMOP common data model. The DQD assessment involved a total of 3,570 individual evaluations. Each evaluation compared the outcome against a predefined threshold. A 'FAIL' occurred when the percentage of non-compliant rows exceeded the specified threshold value. In this assessment of the primary care OMOP database described here, we achieved an overall pass rate of 97%. Conclusion: The OMOP CDM's widespread international use, support, and training provides a well-established pathway for data standardisation in collaborative research. Its compatibility allows the sharing of analysis packages across local and international research groups, which facilitates rapid and reproducible data comparisons. A suite of open-source tools, including the OHDSI Data Quality Dashboard (Version 1.4.1), supports the model. Its simplicity and standards-based approach facilitates adoption and integration into existing data processes.

How to customize common data models for rare diseases: an OMOP-based implementation and lessons learned

Review of Key Elements in Developing a Common Data Model for Rare Diseases: Identifying Common Success Factors

Semantic modelling of common data elements for rare disease registries, and a prototype workflow for their deployment over registry data

Ontologizing health systems data at scale: making translational discovery a reality

Conceptual design of a generic data harmonization process for OMOP common data model

Adoption of the OMOP CDM for Cancer Research using Real-world Data: Current Status and Opportunities

Opportunities and Challenges for Machine Learning in Rare Diseases

Feasibility and utility of applications of the common data model to multiple, disparate observational health databases

Secondary use of patient data within decentralized studies using the example of rare diseases in Germany: A data scientist's exploration of process and lessons learned

Lessons learned from the RE(ACT) conference on medical devices for rare diseases

Annotating Cohort Data Elements with OHDSI Common Data Model to Promote Research Reproducibility

Disease Progression Modeling Workbench 360

Model‐Informed Approach Supporting Drug Development and Regulatory Evaluation for Rare Diseases

Leveraging Generative AI to Accelerate Biocuration of Medical Actions for Rare Disease

A Multimodal Approach as a Model for Rare Disorders

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD)

Transforming Primary Care Data Into the Observational Medical Outcomes Partnership Common Data Model: Development and Usability Study

Natural History and Real‐World Data in Rare Diseases: Applications, Limitations, and Future Perspectives

The OMOP common data model in Australian primary care data: Building a quality research ready harmonised dataset